Benign prostatic hyperplasia (BPH) refers to a condition where the prostate gets enlarged or it could be defined as a noncancerous increase in the size of the prostate gland. Various several different types of prostate laser surgery, such as Holmium laser ablation of the prostate (HoLAP), Holmium laser enucleation of the prostate (HoLEP) and Photoselective vaporization of the prostate (PVP).
Frequently Asked Questions
The market is segmented based on Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Segmentation, By Product (Argon, Carbon Dioxide YAG Laser, Diode Laser, Others), Medium Base (Gas, Liquid, Solid), Modality (Table Top, Fixed, Trolley Mounted),Application (Holmium Laser Enucleation Of The Prostate (HOLEP), Holmium Laser Ablation Of The Prostate (HOLAP), Photoselective Vaporization Of The Prostate (PVP)), End User (Ambulatory Surgical Centres (ASC), Urology Centre, Hospitals, Speciality Clinics, Others) – Industry Trends and Forecast to 2032
.
The Global Laser Bph Devices Market size was valued at USD 553.13 USD Million in 2024.
The Global Laser Bph Devices Market is projected to grow at a CAGR of 6.6% during the forecast period of 2025 to 2032.
The major players operating in the market include Endo Pharmaceuticals , KARL STORZ, Lumenis, Olympus Winter, UBE GMBH, Urologix LLC, Boston Scientific Corporation, LISA Laser USA, ProArc Medical, Urovision, Urotech, Teleflex orporated, Richard Wolf GmbH, BD, biolitec AG, Coloplast Corp.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
